DolCas Biotech has attained two Health Canada natural product licenses, one for its concentrated turmeric extract, Curcugen and the other for Ginfort, a ginger extract in powdered format. Produced by Olene Life Sciences, the two ingredient brands are research-backed for clinical efficacy and safety, and are solely distributed by DolCas.
Products with such licenses have been assessed by Health Canada and found to be safe, effective, and of high quality under their recommended conditions of use. You can identify licensed natural health products by an eight-digit Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM) on the label.
According to a Mordor market intelligence report, the Canadian nutraceuticals market is expected to witness a CAGR of 5.62% from 2022-2027. Statistics Canada recently reported that vitamin and supplement sales in the country increased from some C$740M in the last quarter of 2019 to nearly C$800M in the first quarter of 2020. The surge in demand for different supplements also led to an upsurge in demand for nutraceuticals in the Canadian market.
The Mordor report also noted that, “personal nutrition” is a current trend of interest for consumers and that “the biggest issue faced by nutraceutical companies operating in Canada is complying with the stringent health regulations in Canada. Unlike many countries throughout the world, Canada has very stringent regulations governing the sale of dietary supplements.”
The first license, NPN# 80121176, supports the well-known health benefits of antioxidant curcuminoids in Curcugen, a 50% concentrated, water-dispersible formula. Curcugen’s patent-pending composition of curcuminoids is natively complexed to other naturally-occurring turmeric constituents in a turmeric oleoresin matrix that provides proven bioavailability enhancement.